SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt reports Profit after tax of Rs 298.20 Mln, in the June 2023 quarter

23 Aug 2023 Evaluate
With no major difference for the quarter endedJune 2023 , the total revenue stood at Rs. 3011.80  millions.The Net Profit of the company registered a slight decline of -27.60% to Rs. 298.20  millions from Rs. 411.90 millions.The company reported a degrowth in operating Profit to 508.00 millions from 621.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202306 202206 % Var
Sales 3011.80 2958.90 1.79 12296.20 11144.10 10.34 12296.20 11144.10 10.34
Other Income 54.60 31.00 76.13 183.90 131.90 39.42 183.90 131.90 39.42
PBIDT 508.00 621.40 -18.25 3430.70 2808.70 22.15 3430.70 2808.70 22.15
Interest 1.70 0.20 750.00 7.70 4.20 83.33 7.70 4.20 83.33
PBDT 506.30 621.20 -18.50 3423.00 2804.50 22.05 3423.00 2804.50 22.05
Depreciation 65.00 74.70 -12.99 281.00 270.80 3.77 281.00 270.80 3.77
PBT 441.30 546.50 -19.25 3142.00 2533.70 24.01 3142.00 2533.70 24.01
TAX 143.10 134.60 6.32 847.30 608.50 39.24 847.30 608.50 39.24
Deferred Tax -8.00 11.30 -170.80 -50.60 0.40 -12750.00 -50.60 0.40 -12750.00
PAT 298.20 411.90 -27.60 2294.70 1925.20 19.19 2294.70 1925.20 19.19
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 16.87 21.00 -19.68 27.90 25.20 10.70 27.90 25.20 10.70

Procter&Gamble Healt Share Price

5150.25 -44.30 (-0.85%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×